ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Aug 06, 2015 13:32 JST
Nobel Prize Winner for Economics, Dr. Myron Scholes Bought Shares of C.banner
Focusing on Chinese High-quality Retailer, Optimistic about the Company's Future Development
HONG KONG, Aug 06, 2015 - (ACN Newswire) - C.banner International Holdings Limited ("C.banner" or the "Company", together with its subsidiaries, the "Group", stock code: 1028), the second largest retailer of middle-to-high-end women's formal and leisure footwear in the PRC, has bought back its stock shares from market frequently in July, reflecting that the management has sufficient confidence in the Company's future and is devoted to maintain the interest for shareholders. It has learned that the famous American economist, Nobel Prize Winner for Economics, Dr. Myron Scholes bought Company stock recently, indicating his confidence in the value and future development of the Company. He also expressed his intention to increase shareholding of C.banner in the future.
Dr. Myron Scholes is a famous Canadian-American economist. He earned his Ph.D. at the University of Chicago and was a professor at MIT, University of Chicago and currently is an Emeritus Professor at Stanford University. As co-originator of the Black-Scholes options pricing model, he was awarded the Nobel Memorial Prize in Economic Sciences in 1997 with Prof. Robert C. Merton of Harvard University for their great contribution in developing the technology to value derivatives and hailed as the "Father of Current Derivatives Theory".
Dr. Myron Scholes conducts research on the implications of the shift in the Chinese economy from an infrastructure to more of a consumer basis for the growth of the economy. He visits China from time to time. He expressed confidence in the Company's financial condition and its future business prospects, which lead to his initial investment and his intended further open-market purchase of C.banner's shares.
Mr. Chen Yixi, Chairman of C.banner said, "The Company feels honored to attract attention and investment of a famous American economist. C.banner actively adjusts its strategies to meet changing conditions in a complicated and challenging economic environment. We expect a long-term investment interest from Dr. Myron Scholes. The Company will further enhance its strength and profitability to maximize the value for each investor."
Sectors: Daily Finance
Copyright ©2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
Marketing Authorization Application for In-house Developed Insomnia Drug Lemborexant Accepted for Evaluation by European Medicines Agency (EMA)
Jul 18, 2026 00:24 JST
Hitachi and NVIDIA collaborate to advance HMAX and enable end-to-end autonomous operations through the integrated control of physical AI
Jul 17, 2026 23:35 JST
Toyota's First "BE creation" Spin-Off Begins Operations in Japan
Jul 17, 2026 23:00 JST
MHI Advances AI Infrastructure Commercialization with U.S. Deployment of 10MW-Class Chiller and MCP Development
Jul 17, 2026 22:47 JST
Noetra Launches Full-Scale R&D for Japan-Developed Multimodal Foundation Model
Jul 17, 2026 22:16 JST
Mitsubishi Motors Launches the Xforce HEV in Indonesia
Jul 17, 2026 21:47 JST
Fujitsu to explore physical AI development and implementation across industries with FANUC, Yaskawa Electric, and Kawasaki Heavy Industries integrating NVIDIA technology
Jul 17, 2026 21:05 JST
JCB Celebrates 30 Years of Trust, Honoring 70 Years of Japan-Philippines Friendship
Jul 17, 2026 10:00 JST
TANAKA Commences Operation of "TANAKA H2 Nexus", One of Japan's Largest 500 kW Pure Hydrogen Fuel Cell Power Generation Facilities
Jul 16, 2026 22:00 JST
LEQEMBI(R) Real-World LEADER Study Presented at AAIC(R) 2026 Finds Over 75% of Early Alzheimer's Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment
Jul 16, 2026 00:18 JST
FDA Approves LEQEMBI IQLIK(R) (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer's Disease
Jul 15, 2026 23:51 JST
Eisai Presents Latest Findings Showed Etalanetug Reduced Alzheimer's Disease Tau Tangle-Specific Plasma Biomarker MTBR-tau243 at Alzheimer's Association International Conference(R) (AAIC(R)) 2026
Jul 15, 2026 23:21 JST
NEC develops world's first proprietary-AI technology to rapidly generate highly detailed 3D models solely from general-purpose camera footage while automatically removing unnecessary subjects
Jul 15, 2026 22:53 JST
Hitachi Rail achieves EcoVadis platinum medal, ranking among the top 1% of companies worldwide for sustainability performance
Jul 15, 2026 22:35 JST
Anime Tokyo Station Reaches 300,000 Visitors!
Jul 15, 2026 11:00 JST
Fujitsu launches AI-driven modernization service to accelerate legacy system transformation
Jul 14, 2026 19:12 JST
Anime Tokyo Station: TV Anime "BLEACH: THE BLOOD WARFARE - The Calamity" Special Exhibition
Jul 14, 2026 11:00 JST
JCB Signs Memorandum of Understanding with Circle to Explore Collaboration Utilizing Stablecoins
Jul 14, 2026 10:00 JST
Mitsubishi Power Receives Contract to Supply Boilers for Fuel Conversion Work at Existing Thermal Power Plants in Saudi Arabia
Jul 14, 2026 00:58 JST
Fujitsu developed an AI Agent to collaborate with store managers for AEON Food Style's strategic store operations
Jul 14, 2026 00:38 JST
More Latest Release >>